Clinical trial
The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in…
NCT00302250 · Synvista Therapeutics, Inc, Industry · Completed
Key facts
| NCT number | NCT00302250 |
|---|---|
| Title | The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension |
| Official title | Study of The Effect of Vascular Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension Before and After Receiving Oral Alagebrium or Placebo for 8 Weeks (STRETCH) |
| Lead sponsor | Synvista Therapeutics, Inc, Industry |
| Collaborators | National Institutes of Health (NIH) NIH National Heart and Lung Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | ALT-711 (alagebrium chloride) |
| Enrollment | 70 |
| Start date | Feb 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 14, 2006 |
| Last update posted | Mar 22, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: